These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38041048)

  • 1. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
    Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
    BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J
    Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens.
    Švajdler M; Mezencev R; Šašková B; Ondič O; Mukenšnábl P; Michal M
    Hum Pathol; 2019 Mar; 85():58-64. PubMed ID: 30385371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary.
    Cho WK; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):925-933. PubMed ID: 31858242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary.
    Keller LM; Galloway TJ; Holdbrook T; Ruth K; Yang D; Dubyk C; Flieder D; Lango MN; Mehra R; Burtness B; Ridge JA
    Head Neck; 2014 Dec; 36(12):1677-84. PubMed ID: 24115269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases.
    Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X
    Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic metastases from carcinomas of unknown primary site.
    Pouessel D; Thezenas S; Culine S; Becht C; Senesse P; Ychou M
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1224-32. PubMed ID: 16518276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker.
    Vent J; Haidle B; Wedemeyer I; Huebbers C; Siefer O; Semrau R; Preuss SF; Klussmann J
    Head Neck; 2013 Nov; 35(11):1521-6. PubMed ID: 23345170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
    Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
    Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
    BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.
    Yang Z; Klimstra DS; Hruban RH; Tang LH
    Am J Surg Pathol; 2017 Jul; 41(7):915-922. PubMed ID: 28498280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
    Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
    Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
    Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
    PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.
    Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T
    ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of postoperative pathological diagnosis of lung cancer in China: a multicenter big data study].
    ;
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):882-890. PubMed ID: 34344071
    [No Abstract]   [Full Text] [Related]  

  • 18. Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin.
    Du T; Pan L; Zheng C; Chen K; Yang Y; Chen J; Chao X; Li M; Lu J; Luo R; Zhang J; Wu Y; He J; Jiang D; Sun P
    Breast Cancer Res; 2022 Oct; 24(1):70. PubMed ID: 36284362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.
    Pentheroudakis G; Spector Y; Krikelis D; Kotoula V; Meiri E; Malamou-Mitsi V; Fountzilas G; Sanden M; Pavlidis N; Benjamin H; Aharonov R
    Clin Exp Metastasis; 2013 Apr; 30(4):431-9. PubMed ID: 23124598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
    Laurent E; Begueret H; Bonhomme B; Veillon R; Thumerel M; Velasco V; Brouste V; Hoppe S; Fournier M; Grellety T; MacGrogan G
    Am J Surg Pathol; 2019 Mar; 43(3):293-302. PubMed ID: 30628926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.